Comparing multiple AD mouse models, Wilcock and colleagues concluded that reduced levels of Kir4.1 mRNA and protein are associated with cerebral amyloid angiopathy (CAA), a condition that affects 70% of AD patients (Kalaria and Ballard (1999) [250]). This evidence concerns the gene KCNJ10 and Alzheimer disease.